EQUITY ALERT: Rosen Law Firm Encourages NeoGenomics, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action – NEOBusiness Wire • 12/07/22
INVESTOR ALERT: Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of NeoGenomics, Inc. (NEO) InvestorsBusiness Wire • 12/07/22
Kirby McInerney LLP Announces the Filing of a Securities Class Action on Behalf of NeoGenomics, Inc. (NEO) InvestorsBusiness Wire • 12/07/22
INVESTOR ALERT: NeoGenomics, Inc. Investors with Substantial Losses Have Opportunity to Lead the NeoGenomics Class Action Lawsuit - NEOBusiness Wire • 12/07/22
INVESTOR ACTION DEADLINE: The Schall Law Firm Files Class Action on Behalf of Investors in NeoGenomics, Inc. and Advises Shareholders with Losses of $500,000 to Contact the FirmAccesswire • 12/07/22
CORRECTING and REPLACING NEOGENOMICS INVESTOR ALERT: Gibbs Law Group Files Class Action Lawsuit on Behalf of NEO InvestorsBusiness Wire • 12/07/22
SHAREHOLDER ACTION ALERT: The Schall Law Firm Files Class Action on Behalf of Investors in NeoGenomics, Inc. and Advises Shareholders with Losses of $100,000 to Contact the FirmBusiness Wire • 12/07/22
RaDaR(R) Assay Demonstrates Clinical Potential for Detecting Disease Recurrence Across All Types of Early Breast Cancer, Including Triple Negative DiseaseAccesswire • 11/21/22
NeoGenomics and ImmunoGen Launch New Program Giving Ovarian Cancer Patients Access to Novel FR Biomarker Testing to Support the Launch of ELAHERE(TM)Accesswire • 11/18/22
Analysts Estimate NeoGenomics (NEO) to Report a Decline in Earnings: What to Look Out forZacks Investment Research • 11/01/22
NeoGenomics Provides Update on MolDX Submission for CRC and RaDaR(TM) Commercial LaunchAccesswire • 10/28/22
NeoGenomics Schedules its Third Quarter 2022 Earnings Release for November 8, 2022Accesswire • 10/13/22
Inivata and Collaborators to Present New Data to Support the Application of RaDaR™ MRD Assay Across Tumor Types at ESMO Congress 2022GlobeNewsWire • 09/07/22
NeoGenomics and Liquid Biopsy Subsidiary Inivata and Collaborators to Present New Data at ESMO Congress 2022Accesswire • 09/07/22
Neo Performance Materials Inc. (NOPMF) CEO Constantine Karayannopoulos on Q2 2022 Results - Earnings Call TranscriptSeeking Alpha • 08/13/22
NeoGenomics, Inc.'s (NEO) CEO Lynn Tetrault on Q2 2022 Results - Earnings Call TranscriptSeeking Alpha • 08/09/22